Search Results 571-580 of 16248 for VEO-IBD

  1. Movement disorders - Doctors and departments - Mayo Clinic

    Learn about the different types of neurological conditions that affect movement.

  2. Implantable cardioverter-defibrillators (ICDs) - Doctors & Departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  3. Surgery - Clinical trials

    The purpose of this study is to collect adult human blood, cerebrospinal fluid, brain, and spine tissues/fluids at time of surgery in order to conduct ...

  4. Study to Evaluate the Safety, Tolerability and Preliminary Antitumor Activity of INCB059872 in Patients with Relapsed/Refractory Ewing Sarcoma - Mayo Clinic

    The purpose of this study is to evaluate the safety and preliminary anti-tumor activity of INCB059872 in participants with Ewing sarcoma who are refractory or ...

  5. A Study of BBI503 in Adult Patients With Advanced Solid Tumors - Mayo Clinic

    Significant gastrointestinal disorder(s), in the opinion of the Principal Investigator, (e.g., Crohn's disease, ulcerative colitis, extensive gastric resection ...

  6. Congenital heart defects in children - Doctors and departments - Mayo Clinic

    Learn about symptoms, tests and treatments for children born with a problem in the structure of the heart.

  7. A Study to Evaluate the Effectiveness, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera - Mayo Clinic

    Patients with active GI conditions (Crohn's disease, ulcerative colitis, diverticulosis associated colitis, and Behçt's disease); Clinically significant ...

  8. Movement disorders - Doctors and departments - Mayo Clinic

    Learn about the different types of neurological conditions that affect movement.

  9. Normal Values for High-Resolution Anorectal Manometry in IPAA - Mayo Clinic

    Patients must be between the ages of 18 and 65, who have undergone TAC with IPAA for any indication (i.e., ulcerative colitis, indeterminate colitis, FAP).

  10. The Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy - Mayo Clinic

    Intestinal obstruction or has inflammatory bowel disease; Active malignancy within the last 5 years; Current GI bleeding or has had a GI hemorrhage within ...